Artisan Partners Limited Partnership Reduces $63M in West Pharmaceutical Services, Inc. ($WST)
Key Points
- Artisan Partners Limited Partnership changed its West Pharmaceutical Services, Inc. ($WST) stake by 6.8% last quarter, cutting to 2,657,893 shares worth $873.97 million.
- Wall Street's consensus rating on $WST is Strong Buy and an average price target of $358.79.
- $WST last traded around $328.82.
Artisan Partners Limited Partnership trimmed its position in West Pharmaceutical Services, Inc. ($WST) by 6.8% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,657,893 shares of West Pharmaceutical Services, Inc. after selling 192,508 shares during the quarter. Artisan Partners Limited Partnership's holdings in West Pharmaceutical Services, Inc. were worth $873.97 million as of its most recent filing.
West Pharmaceutical Services, Inc. ($WST) Stock
West Pharmaceutical Services, Inc. Earnings
West Pharmaceutical Services, Inc. Dividend
Analysts Set New Price Targets
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.